LQDA Liquidia Corp

8-K Current Report
Filed: March 5, 2026
Health Care
Pharmaceutical Preparations

Liquidia Corp (LQDA) 8-K current report filed with SEC EDGAR on March 5, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • Q4 or full-year 2025 earnings results disclosed via press release exhibit, signed March 5, 2026
  • Full financial details in the accompanying exhibit — no key figures included in the 8-K body text

Get deeper insights on Liquidia Corp

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.